At present: There is no FDA approval There is no standard prescription pathway There is no approved supplement classification There is no lawful retail medical distribution model The only compliant framework that exists today is legitimate research distribution , meaning: Supplied for scientific investigation Not sold as treatment Not administered to patients Not marketed for healing or recovery Anything else blurs into non-compliance
Manufacturers of these supplements are just kind of creating a hype to try to be appealing for people looking for a magic potion to help them lose weight. Ozempic, a GLP-1 receptor agonist, helps the pancreas release insulin when blood sugar is high, lowering glucose levels
Neither approved nor specifically prohibited by Health Canada, it remains available as a research chemical for laboratory investigation
Offer is for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg, and $399 per month for Wegovy HD (semaglutide) injection 7.2 mg
Multifocal pigmentation of the oral cavity